Clemens Reinshagen

Executive Director Of Translational Research & BD at PineTree Therapeutics Inc

Clemens Reinshagen has a strong background in translational research, particularly in the field of cancer therapy. With experience in both academia and industry, Clemens has demonstrated expertise in setting up laboratories, managing collaborations, and mentoring research teams. With a Doctor of Medicine degree from the University of Göttingen, Clemens' previous roles at Brigham and Women's Hospital and Massachusetts General Hospital have equipped him with valuable skills in cell-based therapies and CRISPR technology. Currently, as the Executive Director of Translational Research at PineTree Therapeutics Inc, Clemens continues to drive innovation in the development of bispecific antibodies for cancer therapy.

Links

Previous companies

Massachusetts General Hospital logo

Timeline

  • Executive Director Of Translational Research & BD

    March 1, 2024 - present

  • Director of Translational Research

    October, 2021

  • Associate Director of Translational Research

    January, 2019